Successful CAR T-cell therapy reimbursement begins with careful payer-provider collaboration and taking these two approaches.
Managed Healthcare Executive – Health Management
Tag Archives: Tcell
CAR T-cell therapies in treating lymphoma: Pros and cons
Catherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.
Managed Healthcare Executive – Health Management
Three things health execs need to know about CAR T-cell therapy
Here’s your quick guide to understanding how CAR T-cell therapy could affect patients and payers.
Managed Healthcare Executive – Health Management